Following the recent announcement that the UK’s National Health Service (NHS) will subsidize the cost of e-cigarettes prescribed by doctors, some companies are moving to submit products for approval. They must be licensed for medical use through the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
The Financial Times reports that likely applicants include American vaping industry pioneer NJOY, British companies DSL Group (owner of Multivape) and Superdragon, and Irish firm Yatzz Limited.
The paper quotes a regulatory compliance expert’s estimate that approval would likely cost £3-5 million (about $4-6.6 million U.S.).
NJOY, which owns about four percent of the U.S. convenience store/gas station vaping market, sees medical approval as an opportunity to expand its UK footprint. The Financial Times says the company is “far on in the development of its application.” It isn’t known if NJOY will submit a new product or an existing device like the NJOY Ace.
Jim McDonald – Vaping360.com – 2021-12-07.
Want More Investigative Content?
